JATT II Acquisition Corp (JATT) Stock Analysis

$12.000

-0.010 (-0.08%)At close

Loading chart…

High: 12.250
Open: 12.000
VWAP: 12.08
Vol: 14.40K
Mkt Cap: —
Low: 12.000
Amount: 174.05K
EV/EBITDA, TTM: 0.00

JATT II Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and the Company has not engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with the Company. The Company is not engaged in any business operations and has not generated any revenue.

jattacquisition.com/jatt-ii

AI analysis of JATT II Acquisition Corp (JATT)

hold

Currently, Zura Bio Ltd (JATT) is not a strong buy due to its low RSI of 28.678, indicating it is oversold, and a 5-day change of -9.37%. However, it has shown a year-to-date change of +20.00%, suggesting potential for recovery. The main risk is the lack of earnings metrics, with a forward P/E of 0, indicating uncertainty in profitability.

Valuation Metrics

The current forward P/E ratio for JATT II Acquisition Corp (JATT) is 0.00, compared to its 5-year average forward P/E of .

Forward P/E

5Y Average P/E

Current P/E

0.00

Forward EV/EBITDA

5Y Average EV/EBITDA

Current EV/EBITDA

0.00

Forward P/S

5Y Average P/S

Current P/S

0.00

Whales holding JATT

C

Commodore Capital LP

+ HoldingJATT

+34.35%

3M Return

Events Timeline

2026-08-21 (ET)

10:00:00

Jatt II Acquisition Corp Trading Halted Due to Volatility

2026-06-29 (ET)

10:00:00

JATT II Acquisition Corp Ordinary Shares Trading Halted

07:30:00

Talawar Tx and JATT II to Merge, Expected to Raise $285 Million

2026-04-20 (ET)

11:30:00

AEVEX Opens Above $20 in IPO Debut

Show More Events

News

JATT FAQ — answered by Alphio AI

JATT II Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and the Company has not engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with the Company. The Company is not engaged in any business operations and has not generated any revenue. It operates in the Financials sector.

Currently, Zura Bio Ltd (JATT) is not a strong buy due to its low RSI of 28.678, indicating it is oversold, and a 5-day change of -9.37%. However, it has shown a year-to-date change of +20.00%, suggesting potential for recovery. The main risk is the lack of earnings metrics, with a forward P/E of 0, indicating uncertainty in profitability.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.